“The Nymi Band’s biometric authentication capabilities are the key selling points of the device, alongside its proximity-based tap functionality, its cryptographic security, and its on-device authentication.”
Nymi has announced version 3.0 of its flagship biometric wearable device, emphasizing its functionality in mitigating the spread of COVID-19.
The wristband device leverages both fingerprint-based authentication and heart rate biometrics to verify the identity of the wearer. Nymi has been pitching its eponymous wearable as a solution particularly well-suited for sensitive industrial applications that require workers to sign-off on various processes throughout the workday, and has seen some success in recent months in the pharmaceutical industry in particular.
The Nymi Band’s biometric authentication capabilities are the key selling points of the device, alongside its proximity-based tap functionality, its cryptographic security, and its on-device authentication. But in announcing this latest version, Nymi also highlighted the wearable’s location sensing technology, which can be used to facilitate social distancing by tracking when a given device gets in close proximity to another Nymi Band, triggering an alert.
The device can also track contact logs for each user, which can be used for contact tracing purposes.
“The Nymi Band understands if employees have encountered a COVID-19 positive co-worker, the proximity between an employee and dangerous industrial equipment or the location of employees during a crisis,” explained Nymi COO David Rai. “Our technology is designed to add new uses cases as our customers continue their DX evolution.”
Nymi CEO Chris Sullivan, meanwhile, made the broader case for the device. “Many organizations operate in extremely complex and regulated environments that make digital transformation, security and now, with COVID-19, health and safety for every worker a challenge,” he said. “With Nymi, you get a safer, more productive and more secure way to come back to work.”